Skip to main content
. 2023 Nov 2;22(2):259–267. doi: 10.1007/s41105-023-00497-7

Table 1.

Demographic and clinical characteristics by RLS status

RLS negative (n = 376) RLS positive (n = 50) p value
Age (n = 426) 49.5 (11.1) 53.5 (12.3) 0.02
Female gender (n = 426) 234 (62.2%) 38 (76.0%) 0.06
White (n = 426) 281 (74.7%) 40 (80%) 0.42
PSQI > 5 (n = 423) 136 (36.5%) 31 (62.0%) 0.0005
ESS > 10 (n = 424) 35 (9.4%) 7 (14.0%) 0.31
High risk for OSA (n = 424) 37 (9.9%) 6 (12.0%) 0.64
IRLS severity score (n = 50) 10.2 (4.4)
Hypertension (n = 426) 64 (17.0%) 7 (14.0%) 0.59
Diabetes (n = 426) 17 (4.5%) 5 (10.0%) 0.16
Hyperlipidemia (n = 426) 86 (22.9%) 13 (26.0%) 0.62
Current or past smoking (n = 424) 65 (17.4%) 14 (28.0%) 0.07
Current alcohol use (n = 423) 310 (83.1%) 40 (80.0%) 0.58
BMI (n = 389) 27.1 (6.1) 26.7 (6.3) 0.72
Serum ferritin (n = 374) 86.3 (83.2) 75.0 (69.2) 0.39
Hemoglobin (n = 372) 14.0 (2.1) 13.4 (1.4) 0.02
Hematocrit (n = 372) 41.3 (4.7) 39.8 (3.9) 0.049
Creatinine (n = 374) 1.1 (4.5) 0.8 (0.2) 0.33
LDL, mg/dL (n = 373) 108.1 (30.0) 106.8 (31.0) 0.79
HDL, mg/dL (n = 372) 61.3 (18.0) 64.0 (20.9) 0.34

Bold entries indicate statistical significance

Data are presented as mean (standard deviation) or number (percent)

BMI body mass index, BUN blood urea nitrogen, Cr creatinine, ESS Epworth Sleepiness Scale, HDL high density lipoprotein, IRLS International RLS study group severity scale, LDL low density lipoprotein, OSA obstructive sleep apnea, PSQI Pittsburgh Sleep Quality Index, RLS restless legs syndrome